Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Magnus Nylander Biocare AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 52 More Arrow 92 More Arrow 247
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -5 Less Arrow -342 More Arrow 86
EBITDA -7 Less Arrow -343 More Arrow 33
Total assets 392 More Arrow 747 More Arrow 775
Current assets 366 More Arrow 721 More Arrow 749
Current liabilities 252 More Arrow 602 Less Arrow 288
Equity capital 136 More Arrow 141 More Arrow 483
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 1 Equal arrow 1 Less Arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 34.7% Less Arrow 18.9% More Arrow 62.3%
Turnover per employee 52 More Arrow 92
Profit as a percentage of turnover -9.6% Less Arrow -371.7% More Arrow 34.8%
Return on assets (ROA) -1.3% Less Arrow -45.8% More Arrow 11.1%
Current ratio 145.2% Less Arrow 119.8% More Arrow 260.1%
Return on equity (ROE) -3.7% Less Arrow -242.6% More Arrow 17.8%
Change turnover -40 Less Arrow -155 More Arrow -67
Change turnover % -43% Less Arrow -63% More Arrow -21%
Chg. No. of employees 0 More Arrow 1 Less Arrow -1
Chg. No. of employees % 0% -100%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.